Correlation Between Bristol Myers and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Terns Pharmaceuticals, you can compare the effects of market volatilities on Bristol Myers and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Terns Pharmaceuticals.
Diversification Opportunities for Bristol Myers and Terns Pharmaceuticals
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bristol and Terns is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Bristol Myers i.e., Bristol Myers and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bristol Myers and Terns Pharmaceuticals
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.48 times more return on investment than Terns Pharmaceuticals. However, Bristol Myers Squibb is 2.1 times less risky than Terns Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 5,629 in Bristol Myers Squibb on November 18, 2024 and sell it today you would lose (239.00) from holding Bristol Myers Squibb or give up 4.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Bristol Myers Squibb |
| Terns Pharmaceuticals |
Bristol Myers and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Terns Pharmaceuticals
The main advantage of trading using opposite Bristol Myers and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets |